Virtu KCG Holdings’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Virtu KCG Holdings’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-24,755	Closed	-$1.04M	–	3580
2017 Q1	$1.04M	Buy	24,755 +3,695	+18%	+$151K	0.03%	679
2016 Q4	$823K	Buy	+21,060	New	+$857K	0.02%	943
2016 Q2	–	Sell	-11,981	Closed	-$482K	–	3390
2016 Q1	$482K	Buy	11,981 +8,056	+205%	+$341K	0.01%	1224
2015 Q4	$201K	Sell	3,925 -44,941	-92%	-$2.29M	﹤0.01%	2713
2015 Q3	$2.29M	Buy	48,866 +43,012	+735%	+$2.59M	0.04%	377
2015 Q2	$365K	Buy	5,854 +2,536	+76%	+$158K	0.01%	1815
2015 Q1	$205K	Sell	3,318 -982	-23%	-$58.2K	﹤0.01%	2381
2014 Q4	$232K	Sell	4,300 -2,708	-39%	-$148K	﹤0.01%	2694
2014 Q3	$371K	Buy	+7,008	New	+$356K	0.01%	2056
2014 Q2	–	Sell	-70,572	Closed	-$3.31M	–	4120
2014 Q1	$3.31M	Buy	70,572 +38,850	+122%	+$1.83M	0.04%	424
2013 Q4	$1.4M	Buy	31,722 +13,646	+75%	+$568K	0.02%	918
2013 Q3	$695K	Buy	+18,076	New	+$684K	0.01%	1601

Other funds holding XPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return

Virtu KCG Holdings's XPH Position: Q2 2017 in Review

Virtu KCG Holdings sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2017, closing a stake of 24,755 shares — an estimated $1.04M sold.

Virtu KCG Holdings first reported a position in XPH in Q3 2013 and held it in 12 quarters. The position peaked at $3.31M in Q1 2014. 80 funds tracked by Wall St. Rank hold XPH as of Q2 2017.

Virtu KCG Holdings reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 24,755 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2017, an estimated $1.04M.
Virtu KCG Holdings first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2013 and held it in 12 quarters.
Virtu KCG Holdings's State Street SPDR S&P Pharmaceuticals ETF position peaked at $3.31M in Q1 2014.
80 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.